The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Famvir     [2-(acetyloxymethyl)-4-(2- aminopurin-9...

Synonyms: Oravir, FAMCYCLOVIR, famciclovir, Famciclovirum, CHEMBL880, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Famvir


High impact information on Famvir


Chemical compound and disease context of Famvir


Biological context of Famvir


Anatomical context of Famvir


Associations of Famvir with other chemical compounds


Gene context of Famvir


Analytical, diagnostic and therapeutic context of Famvir


  1. Famciclovir for genital herpes. Goldman, B.D. JAMA (1997) [Pubmed]
  2. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group. Tyring, S., Barbarash, R.A., Nahlik, J.E., Cunningham, A., Marley, J., Heng, M., Jones, T., Rea, T., Boon, R., Saltzman, R. Ann. Intern. Med. (1995) [Pubmed]
  3. Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial. Schacker, T., Hu, H.L., Koelle, D.M., Zeh, J., Saltzman, R., Boon, R., Shaughnessy, M., Barnum, G., Corey, L. Ann. Intern. Med. (1998) [Pubmed]
  4. Famciclovir and postherpetic neuralgia. Bassett, K.L., Green, C.J., Wright, J.M. Ann. Intern. Med. (1999) [Pubmed]
  5. Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group. Diaz-Mitoma, F., Sibbald, R.G., Shafran, S.D., Boon, R., Saltzman, R.L. JAMA (1998) [Pubmed]
  6. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group. Sacks, S.L., Aoki, F.Y., Diaz-Mitoma, F., Sellors, J., Shafran, S.D. JAMA (1996) [Pubmed]
  7. Recent advances in varicella-zoster virus infection. Cohen, J.I., Brunell, P.A., Straus, S.E., Krause, P.R. Ann. Intern. Med. (1999) [Pubmed]
  8. Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: a viral dynamics study. Lau, G.K., Tsiang, M., Hou, J., Yuen, S., Carman, W.F., Zhang, L., Gibbs, C.S., Lam, S. Hepatology (2000) [Pubmed]
  9. Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group. Romanowski, B., Aoki, F.Y., Martel, A.Y., Lavender, E.A., Parsons, J.E., Saltzman, R.L. AIDS (2000) [Pubmed]
  10. Hepatitis B virus kinetics and mathematical modeling. Perelson, A.S., Ribeiro, R.M. Semin. Liver Dis. (2004) [Pubmed]
  11. Brivudin (bromovinyl deoxyuridine). Keam, S.J., Chapman, T.M., Figgitt, D.P. Drugs (2004) [Pubmed]
  12. Prostaglandin E plus famciclovir--a new concept for the treatment of severe hepatitis B after liver transplantation. Böker, K.H., Ringe, B., Krüger, M., Pichlmayr, R., Manns, M.P. Transplantation (1994) [Pubmed]
  13. Pharmacokinetics of famciclovir in subjects with varying degrees of renal impairment. Boike, S.C., Pue, M.A., Freed, M.I., Audet, P.R., Fairless, A., Ilson, B.E., Zariffa, N., Jorkasky, D.K. Clin. Pharmacol. Ther. (1994) [Pubmed]
  14. Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation. Lau, G.K., Liang, R., Wu, P.C., Lee, C.K., Lim, W.L., Au, W.Y. J. Hepatol. (1998) [Pubmed]
  15. Persistence of viral replication after anti-HBe seroconversion during antiviral therapy for chronic hepatitis B. Pichoud, C., Berby, F., Stuyver, L., Petit, M.A., Trépo, C., Zoulim, F. J. Hepatol. (2000) [Pubmed]
  16. Evolution of hepatitis B virus polymerase gene sequence during famciclovir therapy for chronic hepatitis B. Seignères, B., Pichoud, C., Ahmed, S.S., Hantz, O., Trépo, C., Zoulim, F. J. Infect. Dis. (2000) [Pubmed]
  17. Differential effects of famciclovir and valaciclovir on the pathogenesis of herpes simplex virus in a murine infection model including reactivation from latency. Thackray, A.M., Field, H.J. J. Infect. Dis. (1996) [Pubmed]
  18. Indirect Sertoli cell-mediated ablation of germ cells in mice expressing the inhibin-alpha promoter/herpes simplex virus thymidine kinase transgene. Ahtiainen, M., Toppari, J., Poutanen, M., Huhtaniemi, I. Biol. Reprod. (2004) [Pubmed]
  19. Thymosin-alpha1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase. Lau, G.K., Nanji, A., Hou, J., Fong, D.Y., Au, W.S., Yuen, S.T., Lin, M., Kung, H.F., Lam, S.K. J. Viral Hepat. (2002) [Pubmed]
  20. Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance. Pichoud, C., Seignères, B., Wang, Z., Trépo, C., Zoulim, F. Hepatology (1999) [Pubmed]
  21. In vitro evaluation of hepatitis B virus polymerase mutations associated with famciclovir resistance. Xiong, X., Yang, H., Westland, C.E., Zou, R., Gibbs, C.S. Hepatology (2000) [Pubmed]
  22. The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro. Delaney, W.E., Yang, H., Westland, C.E., Das, K., Arnold, E., Gibbs, C.S., Miller, M.D., Xiong, S. J. Virol. (2003) [Pubmed]
  23. Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation. Aye, T.T., Bartholomeusz, A., Shaw, T., Bowden, S., Breschkin, A., McMillan, J., Angus, P., Locarnini, S. J. Hepatol. (1997) [Pubmed]
  24. Combination therapy with famciclovir and interferon-alpha for the treatment of chronic hepatitis B. Marques, A.R., Lau, D.T., McKenzie, R., Straus, S.E., Hoofnagle, J.H. J. Infect. Dis. (1998) [Pubmed]
  25. Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir]. Vere Hodge, R.A., Sutton, D., Boyd, M.R., Harnden, M.R., Jarvest, R.L. Antimicrob. Agents Chemother. (1989) [Pubmed]
  26. Famciclovir in chronic hepatitis B: results of a dose-finding study. Trépo, C., Jezek, P., Atkinson, G., Boon, R., Young, C. J. Hepatol. (2000) [Pubmed]
  27. Efficacy of famciclovir treatment in chronic hepatitis B patients with different mutations at position 552 of the DNA polymerase gene. Wolters, L.M., Honkoop, P., Niesters, H.G., de Man, R.A. J. Hepatol. (1998) [Pubmed]
  28. Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation. Tillmann, H.L., Trautwein, C., Bock, T., Böker, K.H., Jäckel, E., Glowienka, M., Oldhafer, K., Bruns, I., Gauthier, J., Condreay, L.D., Raab, H.R., Manns, M.P. Hepatology (1999) [Pubmed]
  29. Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir. Shaw, T., Mok, S.S., Locarnini, S.A. Hepatology (1996) [Pubmed]
  30. Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation. Rayes, N., Seehofer, D., Hopf, U., Neuhaus, R., Naumann, U., Bechstein, W.O., Neuhaus, P. Transplantation (2001) [Pubmed]
  31. The clinical pharmacokinetics of famciclovir. Gill, K.S., Wood, M.J. Clinical pharmacokinetics. (1996) [Pubmed]
  32. Famciclovir treatment of chronic delta hepatitis. Yurdaydin, C., Bozkaya, H., Gürel, S., Tillmann, H.L., Aslan, N., Okçu-Heper, A., Erden, E., Yalçin, K., Iliman, N., Uzunalimoglu, O., Manns, M.P., Bozdayi, A.M. J. Hepatol. (2002) [Pubmed]
WikiGenes - Universities